First time, Delhi scientists decode how malaria parasites multiply
For the first time, scientists have found how malaria parasites multiply rapidly, an advance that may help develop new drugs to combat the deadly disease that affects millions of people globally.
Malaria parasites are transmitted to people through the bites of infected female Anopheles mosquitoes, which infuse the parasite called Plasmodium into humans.
Until now, the mechanism and sites from where DNA replication is initiated, as well as the proteins involved in the process, have been a grey area for scientists.
"During each cycle of multiplication, the genome of the parasite is duplicated through DNA replication. This process of replication begins from some specific sites along the genome, known as Origin of Replication (OriC)," said Suman Kumar Dhar, Professor at the Special Centre for Molecular Medicine, Jawaharlal Nehru University (JNU) in New Delhi.
"Bacterial genomes usually have only one OriC in their genome, but higher organisms such as humans can have multiple such origin sites. Identifying these origin sites in a given genome is a very difficult task," said Professor Dhar.
In a six-year-long study using computational tools and experimental validation, researchers including Assistant Professor Kushal Shah from the Department of Electrical Engineering, Indian Institute of Technology (IIT) Delhi, found that the parasites replicate from multiple sites in the genome which have similar signature motifs found in yeast.
"The frequency of occurrence of these motifs as potential origins in parasite genome is more than that in higher organism genomes, which means that the parasites will multiply very fast at a given time," said Professor Dhar.
The proteins that are involved in this process have also been found, he added.
It can be understood that by inhibiting the function of these proteins and their binding to these replication sites, parasite growth can be stopped.
"Understanding the process of multiplication will lead to finding new drug targets to combat the disease which is burdened by resistance against conventional drugs including the wonder drug Artemisinin, the discovery of which fetched the Nobel prize last year," said Professor Dhar.
Malaria remains endemic in India with approximately 14 per cent of the population, or 184 million people, at high risk of malaria transmission, according to a World Health Organization (WHO) report.